Switzerland is one of the world's wealthiest markets per capita, a global hub for luxury goods, financial services, and pharmaceuticals, and notably — not an EU member. This last point catches many international brands off guard. An EU Trade Mark (EUTM) obtained through EUIPO covers 27 EU member states but provides zero legal protection in Switzerland. Any brand operating in the Swiss market needs a separate filing with the Swiss federal trademark office.
The IGE/IPI: Switzerland's Trademark Authority
The Institut für Geistiges Eigentum (IGE) — or Institut Fédéral de la Propriété Intellectuelle (IPI) in French — is headquartered in Bern, a few kilometers from WIPO. The IGE/IPI handles trademark, patent, and design registrations for Switzerland and Liechtenstein. Swiss trademark law is governed by the Trademark Protection Act (MSchG/LPM).
The IGE/IPI applies substantive examination (absolute grounds) and has a 3-month opposition window post-publication. Registration typically takes 6–9 months for uncontested applications.
The Swiss Watch Industry: Class 14
Switzerland's watchmaking industry (Classes 14 and 37) is among the most trademark-intensive industries in the world. Brands like Rolex, Patek Philippe, Audemars Piguet, Omega, Longines, TAG Heuer, and IWC have decades-deep trademark portfolios covering not only their names but their watch face designs, case shapes, bracelet patterns, and even movement complications. Any brand entering the watch or horological accessories space in Switzerland faces an extraordinary density of prior registrations that must be cleared.
Swiss Made designation: "Swiss Made" is a legally protected origin indication under Swiss law (the "Swissness" regulation, in force since 2017). For watches, at least 60% of manufacturing costs must originate in Switzerland for a brand to use "Swiss Made" on its products. For other goods, origin requirements vary. This is separate from trademark registration but affects brand naming and product labeling for any brand leveraging Swiss-origin positioning.
Pharma and Financial Services
Basel is home to Novartis, Roche, and a cluster of major pharmaceutical companies. Class 5 (pharmaceuticals) filings are among the highest by volume in Swiss trademark applications, and the overlap between trademark rights and regulatory product names creates a complex clearance challenge. Brands in pharma must audit both the Swiss trademark register and the WHO International Nonproprietary Names (INN) list before selecting a pharmaceutical brand name.
Zurich's position as Europe's second-largest financial center (after London) makes Class 36 (financial services) another high-competition area. Swiss banks and insurance companies hold extensive trademark portfolios.
Frequently Asked Questions
What languages does IGE/IPI accept?
Switzerland has four official languages: German, French, Italian, and Romansh. The IGE/IPI accepts filings in German, French, or Italian. International applicants typically use an IP attorney familiar with Swiss filing requirements.
Does Switzerland participate in the Madrid Protocol?
Yes. Switzerland is a member of the Madrid Protocol, allowing international applicants to designate Switzerland in a Madrid international application originating from another member country.